Effectiveness of original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States, September 2022-August 2023

Authors

• Jennifer DeCuir, Centers for Disease Control and Prevention (CDC)
• Jennie H Kwon, Washington University School of Medicine in St. Louis
• et al.

Journal

Influenza and Other Respiratory Viruses

Publication Date

11-1-2024

Volume

18

Issue

11

First Page

e70027

Document Type

Open Access Publication

DOI

10.1111/irv.70027

Rights and Permissions

DeCuir, J., Surie, D., Zhu, Y., Lauring, A., Gaglani, M., McNeal, T., Ghamande, S., Peltan, I., Brown, S., Ginde, A., Steinwand, A., Mohr, N., Gibbs, K., Hager, D., Ali, H., Frosch, A., Gong, M., Mohamed, A., Johnson, N., Srinivasan, V., Steingrub, J., Khan, A., Busse, L., Duggal, A., Wilson, J., Qadir, N., Chang, S., Mallow, C., Kwon, J., Exline, M., Shapiro, N., Columbus, C., Vaughn, I., Ramesh, M., Safdar, B., Mosier, J., Casey, J., Talbot, H. ., Rice, T., Halasa, N., Chappell, J., Grijalva, C., Baughman, A., Womack, K., Rhoads, J., Swan, S., Johnson, C., Lewis, N., Ellington, S., Dawood, F., McMorrow, M., Self, W. and for the Investigating Respiratory Viruses in the Acutely Ill (IVY) Network (2024), Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022–August 2023. Influenza Other Respi Viruses, 18: e70027. https://doi.org/10.1111/irv.70027 Published 2024. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

DeCuir, Jennifer; Kwon, Jennie H; and et al., "Effectiveness of original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States, September 2022-August 2023." Influenza and Other Respiratory Viruses. 18, 11. e70027 (2024).
https://digitalcommons.wustl.edu/oa_4/6975

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.